✦ LIBER ✦

1418 A PHASE-2, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL OF ARAMCHOL FOR THE TREATMENT OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

✍ Scribed by Safadi, R.; Konikoff, F.M.; Oren, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind Randomized Placebo-Contro

✍ ZelberâSagi, Shira; Kessler, Ada; Brazowsky, Eli; Webb, Muriel; Lurie, Yoav; S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 309 KB

868 EFFICACY OF EZETIMIBE FOR THE TREATM

✍ Y. Takeshita; T. Takamura; Y. Kita; H. Misu; K. Arai; T. Yamashita; E. Mizukoshi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Inhibition of 11β-HSD1 with RO5093151 fo

✍ Stefan, Norbert; Ramsauer, Markus; Jordan, Paul; Nowotny, Bettina; Kantartzis, K 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 342 KB

OnabotulinumtoxinA for treatment of chro

✍ Diener, H.; Dodick, D.; Aurora, S.; Turkel, C.; DeGryse, R.; Lipton, R.; Silbers 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

Benzoate, a D-Amino Acid Oxidase Inhibit

✍ Lin, Chieh-Hsin; Chen, Ping-Kun; Chang, Yue-Cune; Chuo, Liang-Jen; Chen, Yan-Syu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Recombinant streptokinase suppositories

✍ Hernández-Bernal, F.; Valenzuela-Silva, C. M.; Quintero-Tabío, L.; Castellanos-S 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB